Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Consolidated Net Income (2023 - 2025)

Rallybio's Consolidated Net Income history spans 3 years, with the latest figure at $16.0 million for Q3 2025.

  • For Q3 2025, Consolidated Net Income rose 247.9% year-over-year to $16.0 million; the TTM value through Sep 2025 reached -$12.9 million, up 80.07%, while the annual FY2024 figure was -$55.5 million, 23.42% up from the prior year.
  • Consolidated Net Income for Q3 2025 was $16.0 million at Rallybio, up from -$9.4 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $16.0 million in Q3 2025 and bottomed at -$19.6 million in Q4 2023.
  • The 3-year median for Consolidated Net Income is -$15.7 million (2024), against an average of -$11.8 million.
  • The largest annual shift saw Consolidated Net Income decreased 9.48% in 2024 before it skyrocketed 247.9% in 2025.
  • A 3-year view of Consolidated Net Income shows it stood at -$19.6 million in 2023, then surged by 45.93% to -$10.6 million in 2024, then surged by 250.9% to $16.0 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Consolidated Net Income are $16.0 million (Q3 2025), -$9.4 million (Q2 2025), and -$8.9 million (Q1 2025).